NCT02052011 - Ranolazine and Microvascular Angina by PET in the Emergency Department | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Microvascular Angina

Interventions

DRUG

Ranolazine

Subjects will take the extended-release Ranolazine for a total of 4 weeks. Subjects will take 500 mg twice daily for the first week and then 1000 mg twice daily for remaining period (Dosing will be adjusted with concomitant use of diltiazem, verapamil, erythromycin, simvastatin or metformin).

DRUG

Placebo

Trial Locations (1)

06510

Yale New Haven Hospital, New Haven